Sahajanand Medical Technologies IPO closes today after 0.83x bids in two days

The initial public offering of Sahajanand Medical Technologies, a maker of heart stents and other cardiovascular devices, enters its final day of bidding on Monday, October 19, 2026, after being subscribed about 0.83 times by the end of the second day. The Rs 475.48 crore issue is priced at Rs 327 to Rs 344 a share and is entirely an offer for sale by existing shareholders, so the company itself will receive no money from it. Bidding opened on Thursday, October 15. Shares are due to be allotted on Wednesday, October 21, and to list on the stock exchanges on Friday, October 23.

Sahajanand Medical Technologies has been trying to reach the stock market for years. In September 2021 it filed papers for a much larger offer of about Rs 1,500 crore, which included fresh shares, and it received the market regulator's approval in December that year, alongside the travel firm ixigo. That plan did not go ahead at the time. The offer now on the table is about a third of that size and contains no new shares at all, which means it is an exit route for existing investors rather than a fund-raise for growth.

That difference matters to anyone weighing a bid. In a pure offer for sale, every rupee goes to the selling shareholders. The company's balance sheet, debt and expansion plans are not helped by the issue, so investors are buying purely into the existing business and its prospects. The returns depend on how the stent and cardiac device business grows after listing, not on new capital being put to work.

The subscription pattern so far also tells a story. Institutional investors have filled their portion, which suggests professional fund managers see value at the offered price. Retail and wealthy individual investors have been slower, and the issue as a whole was still short of full subscription going into the last day. Final-day bidding often changes the picture sharply in Indian IPOs, so the closing figure, released after bidding ends on October 19, will be the number that counts.

The issue also comes during an unusually crowded week for Indian IPOs, with several mainboard offers closing on October 19 and very large issues due to open on October 21. Heavy supply can spread investor money thin, which is one reason smaller issues sometimes see muted retail demand.

For readers interested in India's medical devices sector, the listing will add another domestic maker of advanced cardiac devices to the market. Its trading will offer a fresh reading of how investors value domestic makers of high-end medical devices.

Short-term: Bidding closes at the end of October 19. If the issue is fully subscribed, shares will be allotted on October 21 and trading will begin on October 23. Investors who are allotted shares will see their first price on listing day.

Long-term: A listing gives the company a market value, a currency for future fund-raising and the scrutiny that comes with being public. Its performance after listing will be watched as a test of investor appetite for Indian medical device makers.

Who is affected: Retail, institutional and high-net-worth investors bidding in the IPO; the selling shareholders; the company's employees and management; and other Indian medical device companies considering a listing.

Questions and Answers